Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Gut Microbiome Derived Metabolite Trimethylamine N Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans Hypertension Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N Oxide Pathobiological Relationship of Excessive Dietary Intake of Choline L Carnitine: A TMAO Precursor Associated Aggravation in Heart Failure in Sarcopenic Patients